Article Versions Notes

Saravanakumar K, Sathiyaseelan A, Park S, Kim S-R, Priya VV, Wang M-H. Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy. Pharmaceutics. 2022; 14(5):927. https://doi.org/10.3390/pharmaceutics14050927

Saravanakumar, Kandasamy, Anbazhagan Sathiyaseelan, Soyoung Park, Song-Rae Kim, Veeraraghavan Vishnu Priya, and Myeong-Hyeon Wang. 2022. "Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy" Pharmaceutics 14, no. 5: 927. https://doi.org/10.3390/pharmaceutics14050927

Saravanakumar, K., Sathiyaseelan, A., Park, S., Kim, S. -R., Priya, V. V., & Wang, M. -H. (2022). Monoclonal Antibody Functionalized, and L-lysine α-Oxidase Loaded PEGylated-Chitosan Nanoparticle for HER2/Neu Targeted Breast Cancer Therapy. Pharmaceutics, 14(5), 927. https://doi.org/10.3390/pharmaceutics14050927